#CBD
Sector Continues to Mature – Sector Snapshot on CBD Brands and Opportunities
(OTC: $RLBD) and (NYSE: $ACB), (NYSE: $APHA), (OTC: $TGIFF)
Point
Roberts WA, Delta BC – November 4, 2019 - Investorideas.com, a leading
investor news resource covering cannabis and hemp stocks releases a sector
snapshot reporting on the growth of the CBD industry and how companies are
looking to differentiate their unique brands.
According
to a report ‘Trends in Internet
Searches for Cannabidiol (CBD) in the United States’, Google searches
for CBD are seeing exponential growth as popularity and availability increases.
”Searches for CBD are now rivaling searches for yoga and electronic cigarettes,
with 0.96 and 0.85 of their respective search volumes, and are searched for
more than half as much as dieting.”
Another
recent
report
stated, “As applications for cannabidiol are brought to market across diverse
industries such as cosmetics, health products, food and beverage, pet products,
skin care, and pharmaceuticals, the collective market for CBD sales is expected
to exceed $20 billion in the United States by 2024,” according to BDS
Analytics
and Arcview Market Research.
“We’re
witnessing CBD maturing from a cannabis sub-category into a full-blown industry
of its own,” said Roy Bingham, Co-Founder and CEO of BDS Analytics. “Our growth
forecast for the CBD market, across all distribution channels, predicts a
compound annual growth rate of 49 percent by 2024. This is a great opportunity
for all involved, but it means the road ahead will include decisions that need
to be informed by the best possible data.”
As
major retailers continue to announce their stocking and private label
development of CBD products, BDS Analytics predicts that the majority of CBD
product sales will soon occur in general retail stores, rather than cannabis
dispensaries, as is currently the case. Moving forward, BDS Analytics market
insights indicate that the success of products is dependent on education and
understanding, dosing and consistent labeling.
BDS
Analytics feels CBD is in a unique position compared to other nutraceutical or
supplement ingredients for two reasons: 1) as an active ingredient in cannabis,
it has a storied history of health and wellness use and anecdotal evidence of
efficacy, and 2) it is one of the few natural remedies with scientific basis
for at least some of the claims being made about its curative powers.
Unsurprisingly, consumers are fascinated by the perceived benefits of CBD.
This
growth and drive of the CBD industry is bringing in major branding
opportunities such as sports and celebrity endorsements for each innovative
formula.
Real Brands, Inc. (OTC:
RLBD),
a leading brand building company in the legal Hemp-Derived CBD consumer
products category, announced that it has closed
the previously announced acquisition of the proprietary CBD formulas from
Integrative Medicine US of Coral Springs, Florida. The formulas consist of
Ancient Chinese and other Ancient Herbal Remedies that are paired with the
latest scientific breakthroughs in endocannabinoid systems, nutrients and
hemp-derived CBD.
“We
are pleased to announce the signing of the definitive agreement to acquire
these proprietary formulas," said Real Brands, Inc. CEO, Jerry Pearring.
“Since completing our audit earlier this month, we are now focusing on
launching our brands and E-commerce website,” added Pearring. “We are
concluding the final steps in developing our unique packaging design and
formulations for each of our brands: CBD Pharmacy™, HempAid®, Humboldt Brands®
and Omegahemp™. This acquisition bolsters our efforts to offer consumers
innovative CBD products and, as we previously announced, we intend to use these
formulas for our CBD Pharmacy™ brand and feature the Chinese symbol for healing
in our new logo.”
In
addition, as part of this acquisition, Jonathan Fields, AP DOM, has entered
into an agreement to formulate additional products for Real Brands and become
the initial member of Real Brands, Inc.’s Advisory Board. “I’m pleased to
become a member of the Real Brands team and look forward to applying my
education and ongoing research into traditional eastern medical therapies to
create delivery mechanisms that act synergistically with CBD,” said Fields.
Aphria Inc. (TSX:
APHA)
(NYSE:
APHA)
recently
reported
its results for the first quarter ended August 31, 2019, with a net revenue of
$126.1 million in the first quarter, an increase of 849% from prior year
quarter and a decrease of 2% from the prior quarter, revenue for adult-use
cannabis of $20.0 million in the first quarter, an increase of 8% from the
prior quarter and a net income of $16.4 million and adjusted EBITDA of $1.0
million in the first quarter.
"We
are pleased to report a second consecutive quarter of profitable growth with
strong contribution from our Canadian cannabis operations. Our success was also
driven by our international business and the strength and growth of our brands,
particularly Broken Coast, despite a small fire at our British Columbia
facility at the end of the quarter. This solid start to the year keeps us on
track to achieve our fiscal year 2020 financial outlook," stated Irwin D.
Simon, CEO of Aphria, Inc. "Going forward, we remain focused on our
highest-return priorities both in Canada and internationally as our team
furthers the development of our medical and adult-use cannabis brands to drive
growth through innovation and return value to shareholders."
The
company, through its subsidiary Aphria
Deutschland GmbH launched their CBD-based
nutraceutical, featuring CBD derived from hemp, CannRelief. The brand of
products are being produced in the European Union and distributed by the Company's
subsidiary, CC
Pharma,
which has access to more than 13,000 pharmacies throughout Germany.
"We
are excited to introduce our first brand of CBD products for the German
nutraceutical and cosmetics market," said Jakob Ripshtein, President of
Aphria. "Supported by our extensive distribution network through CC
Pharma, CannRelief provides a natural extension to Aphria's growing business
opportunities in the German medical cannabis market. We look forward to
providing a full range of CannRelief CBD products this year."
CannRelief
CBD oils are being sold in both a 5% and 10% CBD concentration and can be found
in select stores across Germany. A range of skincare and other products,
including creams, serums and masks will be introduced under the CannRelief
brand in a phased rollout in 2019.
Aurora Cannabis
Inc.
(NYSE:
ACB)
(TSX:
ACB),
a Canadian company that's defining the future of cannabis worldwide, and the UFC, the world's premier mixed martial
arts organization, announced their launch of a
joint clinical research program that will produce multiple studies under the
terms of their recently announced partnership.
The ground-breaking research partnership is
aimed at understanding key health and recovery needs of elite athletes in such
a highly physical and competitive sport as mixed martial arts. Research data
will then be used to drive the development of science-backed, hemp-derived CBD
topicals that will be safe and reliable. These new products will help combat
the rapidly growing market of untested CBD treatments currently being used by
high-performance and non-professional athletes.
Once research is complete, any resulting
product will come to life in the US under the new high-performance sports brand
ROAR Sports, a portfolio of high-quality, hemp-derived CBD topical treatments
scientifically formulated with elite athletes in mind. Through analysis of
athlete needs and scientific data, ROAR Sports will challenge the status quo,
seek to alleviate the stresses of competition, and earn designation as the
"Official CBD product of UFC."
The multi-phase clinical study at the UFC
Performance Institute® in Las Vegas will be led by Dr. Jason Dyck,
Chair of Aurora's Global Scientific Oversight Committee; Dr. Kelly Narine,
Aurora's Vice President Global Research and Medical Affairs; and the team of
sports performance experts at the UFC Performance Institute, led by Dr. Duncan
French, UFC Vice President of Performance. Using active UFC athletes on a
strictly voluntary basis, the study will help establish peer-reviewed,
publishable research in this area. Products will be developed in full
compliance with U.S. federal law and with UFC's anti-doping program, which
adheres to WADA and USADA regulations.
"Our partnership with UFC is about
committing to the science that will educate and advocate," said Aurora
CEO, Terry Booth. "We are going to work together to change the way people
think, to change the industry, and to launch the first hemp-derived CBD
products that are backed by scientific research. The brand-building and product
development are all part of our move into the U.S., and in collaboration with
UFC, and we intend to play a major role in that market."
"We know anecdotally that professional
athletes across sports disciplines are turning to hemp-derived CBD treatments
to assist with physical recovery, with varying degrees of success," added
Jason Dyck, Chair of Aurora's Global Scientific Oversight Committee. "The
work we do in partnership with UFC will create an evidence-based,
science-backed pipeline of consistent, and 'clean' hemp-derived CBD topicals
that the high-performance athletes of UFC can rely on to treat the pain,
inflammation, injury and other conditions associated with competing at such a
high level."
"Collaborating with Aurora is the best
way to educate ourselves and our fighters about the impact of CBD on MMA
athletes and our sport," said Dr. Duncan French, UFC's Vice President of
Performance. "We want to apply science and see where it leads us. Ideally, these studies will give us the
clarity we need to determine the effectiveness of hemp-derived CBD on athlete
health and injury recovery."
"Although CBD is allowed under USADA
and WADA regulations, we want to be the leaders on educating UFC athletes on
CBD use," said Jeff Novitzky, UFC Senior Vice President of Athlete Health
& Performance. "Athlete safety is a top priority for UFC, and we will
collaborate with Aurora to ensure that any new products are third-party tested
for all WADA-prohibited substances to make certain they meet WADA
standards."
1933 Industries
Inc. (CSE:
TGIF)
(OTC:
TGIFF),
a vertically integrated cannabis consumer packaged goods company, recently
announced
that it will introduce its newest product, the Birdhouse CBD Balm by Canna Hemp
X™, on November 4th, 2019. The CBD Balm was developed in
collaboration with Birdhouse Skateboards™, targeting the action sports market
and will be available for sale in dispensaries, wellness stores, skate shops
and specialty retailers, including Zumiez in the United States.
Focusing
on the wellness market through the creation of innovative products that enhance
and improve people's lives, the Company's CBD-infused line is nationally
recognized for its quality and purity of ingredients. Building on its already
successful Canna Hemp X™ brand, the new Birdhouse CBD Balm is a must-have for
any athlete in need of fast results before, during, and after exercise. The
quick-acting Birdhouse CBD Balm is specially formulated with a blend of
essential oils, arnica, peppermint, menthol and other natural ingredients. With
broad-spectrum CBD, all Canna Hemp™ products are nanoparticulated to ensure
total transdermal absorption for maximum effects, while being 100% THC-free.
The
sports world is fast embracing the use of cannabidiol or CBD, one of over 100
non-psychoactive and non-addictive compounds extracted from the cannabis plant,
in a variety of new products aimed at enhancing performance and recovery. Pro
and amateur athletes are now advocating CBD as an alternative to opioid use.
"We are just starting to scratch the surface of the many applications
associated with the cannabis plant and we are pleased to be part of a national
conversation about its potential. The anecdotal benefits keep mounting and we
believe that this market is underserved," commented Mr. Chris Rebentisch,
1933 Industries CEO.
He
added, "We constantly improve our formulations through research and we
worked closely with the Birdhouse team over several months to develop a
next-generation CBD topical product that would have wide appeal in the sports
world. We are pleased to unveil the Birdhouse CBD Balm that both companies are
proud to endorse."
Internationally
recognized skateboarding legend Mr. Tony Hawk, Founder of Birdhouse
Skateboards™ said, "The Birdhouse CBD Balm is our first collaboration with
the team at Canna Hemp X™ and was created with skateboarders and athletes of
all levels in mind. Sports like skateboarding require the highest quality
recovery products to sustain longevity. We also hope to create awareness of the
potential of CBD and in making natural products more accessible
nationwide."
As
this CBD industry continues to grow, in many ways almost independent of the
cannabis sector, brand awareness will become essential as consumers gain more
familiarity and awareness of the Hemp/CBD space. As one recent news piece put
it, “CBD
now has ‘a life of its own’”, and it will be the companies able to build their
brands out early through sponsorship agreements, as well as show consistent
quality of their innovative formulas that will stand ahead of the rest.
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third
party news, research and original financial content. Learn about investing in
stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining,
sports biotech, water, renewable energy and more. Investor Idea’s original
branded content includes the following podcasts and columns : Crypto
Corner , Play by Play sports and stock news
column, Investor
Ideas Potcasts Cannabis News and Stocks on
the Move podcast and column, Cleantech and Climate Change , Exploring Mining, the AI Eye .
Disclaimer/Disclosure: Investorideas.com is a
digital publisher of third party sourced news, articles and equity research as
well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investing involves risk and possible losses of all investment. This site is
currently compensated for news publication and distribution, social media and
marketing, content creation and more. Disclosure is posted for each compensated
news release, content published /created if required but otherwise the news was
not compensated for and was published for the sole interest of our readers and
followers. Contact management and IR of each company directly regarding
specific questions. Disclosure:
this news article featuring Real Brands, Inc. RLBD is a paid for news release
on Investorideas.com – third party (two thousand) More
disclaimer info: https://www.investorideas.com/About/Disclaimer.asp
Learn more about publishing your news release and our other news services on
the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and
tickertagstocknews.com
Global investors must adhere to regulations of each country.
Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Follow us on Social Media
Contact Investorideas.com
800-665-0411
